에서 실시간으로 운영 중이에요! 자세히 알아보기

Organigram Holdings

OGI

시가총액 US$1.34억

0.9267 USD

-0.0049

0.53%

장 마감 시점 업데이트됨 10월 16일 PM 4:00 EDT

프리마켓

시간외 거래

0.9196

-0.0071

0.77%

1일

-0.53%

5일

-2.73%

1개월

-12.58%

3개월

6.37%

6개월

-39.03%

연초 이후

-46.43%

1년

-50.97%

5년

-89.52%

10년

-97.03%

소개: Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

직원 수: 1,137

건강관리 의약품 제조업체 - 전문의약품 및 제네릭

뉴스

긍정적

중립

부정적

투자 심리 3개월

긍정적 16.7%

중립 83.3%

부정적 0%

Organigram Provides Update on Integration of Sanity Group and Unified Global Operating Model

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1 and a growing global cannabis platform, today provided an update on the previously announced accelerated integration of Sanity Group GmbH (“Sanity Group”) and unified global operating model, which completes the integration of Sanity Group and aligns the Company as one enterprise. The Company expects these actions, which include a series of oper.

Organigram Provides Update on Integration of Sanity Group and Unified Global Operating Model

Organigram Global Inc. (OGI:CA) Discusses Strategic Priorities, Growth Initiatives, and Insights from Production Facilities Transcript

Organigram Global Inc. (OGI:CA) Discusses Strategic Priorities, Growth Initiatives, and Insights from Production Facilities Transcript

Organigram Global Inc. (OGI:CA) Discusses Strategic Priorities, Growth Initiatives, and Insights from Production Facilities Transcript

Organigram Global Targets Profitable Growth With Canada Focus and German Expansion

Organigram Global NASDAQ: OGI outlined a strategy centered on protecting its Canadian market position while increasing profitability, expanding internationally through its Sanity Group acquisition, improving manufacturing efficiency and applying stricter capital-allocation discipline.

Organigram Global Targets Profitable Growth With Canada Focus and German Expansion

Organigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on X

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram") is pleased to announce that the 2026 OG Investor Session will premiere today, September 30, 2026, at 4:00 p.m. ET on the Company's X account at https://x.com/Organigram_Inc. The session will also be simulcast on Organigram's LinkedIn and YouTube channels. “We designed this year's OG Investor Session around the questions we hear most often from investors — where the next phase of growth come.

Organigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on X

Organigram Global to Host 2026 OG Investor Session

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform, today announced details of its 2026 OG Investor Session. “Since our last investor session, we've welcomed a new leadership team, completed our first full quarter with Sanity Group, and sharpened our strategy for the years ahead. We look forward to updating our stakeholders on how we're aligning Organigram.

Organigram Global to Host 2026 OG Investor Session

Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram” or the “Company”) today announced an important milestone in its global growth strategy through the accelerated integration of Sanity Group GmbH (“Sanity”) and the alignment of leadership, operations and market development activities across the combined organization. To support the combined organization, Organigram has appointed Finn Age Hänsel as President, Rest of World & Chief Strategy Officer, and Adr.

Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure

Organigram Global Inc. (OGI:CA) Q3 2026 Earnings Call Transcript

Organigram Global Inc. (OGI:CA) Q3 2026 Earnings Call Transcript

Organigram Global Inc. (OGI:CA) Q3 2026 Earnings Call Transcript

Zacks Investment Research

OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates

OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.03 per share a year ago.

OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates

Organigram Global Q3 Earnings Call Highlights

Organigram Global NASDAQ: OGI reported record third-quarter fiscal 2026 revenue and adjusted EBITDA, aided by the consolidation of Germany-based Sanity Group and improving performance in several Canadian cannabis categories.

Organigram Global Q3 Earnings Call Highlights

Organigram Reports Record Third Quarter Fiscal 2026 Results

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share2 and a growing global cannabis platform following its acquisition of Sanity Group GmbH (“Sanity” or “Sanity Group”), today announced its results for the third quarter ended June 30, 2026 (“Q3 Fiscal 2026” or “Q3”). Q3 FISCAL 2026 HIGHLIGHTS Gross Revenue: $145.1 million (+32% year-over-year). Net Revenue: $105.8 million (+49% year-over-year). A.

Organigram Reports Record Third Quarter Fiscal 2026 Results

뉴스 순위 보기

Lightweight Charts™를 사용해 가격 차트를 구현했어요.